IL6 and myeloid sarcoma: It has been proven that excessive synthesis of IL-6 can trigger diseases, proceeding with autoimmunity, such as rheumatoid arthritis (RA) or indeed MS, where the action of Th17 cells is considered a key cause of disease onset [20].